Marion Vetter

2.8k total citations · 1 hit paper
39 papers, 1.9k citations indexed

About

Marion Vetter is a scholar working on Surgery, Pharmacy and Physiology. According to data from OpenAlex, Marion Vetter has authored 39 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Surgery, 13 papers in Pharmacy and 11 papers in Physiology. Recurrent topics in Marion Vetter's work include Obesity and Health Practices (13 papers), Bariatric Surgery and Outcomes (11 papers) and Diet and metabolism studies (11 papers). Marion Vetter is often cited by papers focused on Obesity and Health Practices (13 papers), Bariatric Surgery and Outcomes (11 papers) and Diet and metabolism studies (11 papers). Marion Vetter collaborates with scholars based in United States, Canada and Spain. Marion Vetter's co-authors include Thomas A. Wadden, David B. Sarwer, Reneé H. Moore, Sheri Volger, Jesse Chittams, Sharon J. Herring, Nirav R. Shah, Adina Kalet, Lisa K. Diewald and Robert I. Berkowitz and has published in prestigious journals such as New England Journal of Medicine, Annals of Internal Medicine and Gastroenterology.

In The Last Decade

Marion Vetter

38 papers receiving 1.8k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Two-Year Randomized Trial of Obesity Treatment in Primary Care Practice

2011 381 citations Thomas A. Wadden, Sheri Volger et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Marion Vetter United States	20	718	634	552	464	457	39	1.9k
Elizabeth Konz United States	4	664 0.9×	306 0.5×	203 0.4×	500 1.1×	247 0.5×	7	1.3k
Mary A. Hoskin United States	9	535 0.7×	294 0.5×	170 0.3×	436 0.9×	728 1.6×	17	1.5k
E. Ur Canada	16	399 0.6×	264 0.4×	236 0.4×	414 0.9×	403 0.9×	29	1.6k
Tania Markovic Australia	24	909 1.3×	178 0.3×	506 0.9×	628 1.4×	431 0.9×	85	2.1k
Elizabeth Delbridge Australia	9	1.1k 1.6×	236 0.4×	322 0.6×	417 0.9×	420 0.9×	10	1.7k
Sheri Volger United States	20	272 0.4×	402 0.6×	208 0.4×	413 0.9×	180 0.4×	42	1.4k
Justin R. Ryder United States	23	424 0.6×	179 0.3×	300 0.5×	535 1.2×	278 0.6×	73	1.4k
MEJ Lean United Kingdom	16	607 0.8×	239 0.4×	173 0.3×	565 1.2×	428 0.9×	21	1.7k
Katrina Purcell Australia	9	1.0k 1.4×	221 0.3×	299 0.5×	369 0.8×	403 0.9×	11	1.6k
Claudia K. Fox United States	22	302 0.4×	168 0.3×	178 0.3×	587 1.3×	420 0.9×	60	1.5k

Countries citing papers authored by Marion Vetter

Since Specialization

Citations

This map shows the geographic impact of Marion Vetter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marion Vetter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marion Vetter more than expected).

Fields of papers citing papers by Marion Vetter

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marion Vetter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marion Vetter. The network helps show where Marion Vetter may publish in the future.

Co-authorship network of co-authors of Marion Vetter

This figure shows the co-authorship network connecting the top 25 collaborators of Marion Vetter. A scholar is included among the top collaborators of Marion Vetter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marion Vetter. Marion Vetter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Steinwurz, Flávio, Silvio Danese, Tadakazu Hisamatsu, et al.. (2025). Efficacy and Safety of Guselkumab Subcutaneous Induction and Maintenance in Participants With Moderately to Severely Active Crohn’s Disease: Results From the Phase 3 GRAVITI Study. Gastroenterology. 169(2). 308–325. 12 indexed citations

Steinwurz, Flávio, Silvio Danese, Tadakazu Hisamatsu, et al.. (2024). S1052 Efficacy and Safety of Subcutaneous Guselkumab Induction Therapy in Patients With Moderately to Severely Active Crohn’s Disease: Results Through Week 48 From the Phase 3 GRAVITI Study. The American Journal of Gastroenterology. 119(10S). S740–S741. 8 indexed citations

Sands, Bruce E., Julián Panés, Brian G. Feagan, et al.. (2024). Qualitative and Psychometric Evaluation of 29-Item Patient-Reported Outcomes Measurement Information System® to Assess General Health-Related Quality of Life in Patients With Moderately to Severely Active Inflammatory Bowel Disease. Value in Health. 27(9). 1225–1234. 3 indexed citations

Feagan, Brian G., William J. Sandborn, Bruce E. Sands, et al.. (2023). Qualitative and psychometric evaluation of the PROMIS®-Fatigue SF-7a scale to assess fatigue in patients with moderately to severely active inflammatory bowel disease. Journal of Patient-Reported Outcomes. 7(1). 115–115. 6 indexed citations

Feagan, Brian G., Bruce E. Sands, William J. Sandborn, et al.. (2022). S716 Induction Combination Therapy With Guselkumab and Golimumab Followed by Guselkumab Monotherapy Maintenance: Results of the Phase 2a, Randomized, Double-Blind, Proof-of-Concept VEGA Study. The American Journal of Gastroenterology. 117(10S). e499–e500.

Vetter, Marion, Kristina Johnsson, Elise Hardy, Hui Wang, & Nayyar Iqbal. (2019). Pancreatitis Incidence in the Exenatide BID, Exenatide QW, and Exenatide QW Suspension Development Programs: Pooled Analysis of 35 Clinical Trials. Diabetes Therapy. 10(4). 1249–1270. 5 indexed citations

Young, Tina C., Subasree Srinivasan, Marion Vetter, et al.. (2017). A Systematic Review and Pooled Analysis of Select Safety Parameters Among Normal Healthy Volunteers Taking Placebo in Phase 1 Clinical Trials. The Journal of Clinical Pharmacology. 57(9). 1079–1087. 6 indexed citations

Gadde, Kishore M., et al.. (2017). Efficacy and safety of autoinjected exenatide once‐weekly suspension versus sitagliptin or placebo with metformin in patients with type 2 diabetes: T he DURATION‐NEO ‐2 randomized clinical study. Diabetes Obesity and Metabolism. 19(7). 979–988. 42 indexed citations

Alamuddin, Naji, Marion Vetter, Rexford S. Ahima, et al.. (2016). Changes in Fasting and Prandial Gut and Adiposity Hormones Following Vertical Sleeve Gastrectomy or Roux-en-Y-Gastric Bypass: an 18-Month Prospective Study. Obesity Surgery. 27(6). 1563–1572. 64 indexed citations

10.

Alonso, Álvaro, Judy Bahnson, Sarah A. Gaussoin, et al.. (2015). Effect of an intensive lifestyle intervention on atrial fibrillation risk in individuals with type 2 diabetes: The Look AHEAD randomized trial. American Heart Journal. 170(4). 770–777.e5. 66 indexed citations

11.

Vetter, Marion, Anastassia Amaro, & Sheri Volger. (2014). Nutritional Management of Type 2 Diabetes Mellitus and Obesity and Pharmacologic Therapies to Facilitate Weight Loss. Postgraduate Medicine. 126(1). 139–152. 12 indexed citations

12.

Vetter, Marion, Thomas A. Wadden, Christopher Vinnard, et al.. (2013). Gender differences in the relationship between symptoms of depression and high-sensitivity CRP. International Journal of Obesity. 37(S1). S38–S43. 55 indexed citations

13.

Sarwer, David B., Scott Ritter, Thomas A. Wadden, et al.. (2012). Physicians' attitudes about referring their type 2 diabetes patients for bariatric surgery. Surgery for Obesity and Related Diseases. 8(4). 381–386. 32 indexed citations

14.

Wadden, Thomas A., Sheri Volger, David B. Sarwer, et al.. (2011). A Two-Year Randomized Trial of Obesity Treatment in Primary Care Practice. New England Journal of Medicine. 365(21). 1969–1979. 381 indexed citations breakdown →

15.

Vetter, Marion, Lucy F. Faulconbridge, Victoria L. Webb, & Thomas A. Wadden. (2010). Behavioral and pharmacologic therapies for obesity. Nature Reviews Endocrinology. 6(10). 578–588. 93 indexed citations

16.

Vetter, Marion, Marion Vetter, Alisha N. Wade, et al.. (2010). Effect of a low-carbohydrate diet versus a low-fat, calorie-restricted diet on adipokine levels in obese, diabetic participants. Diabetes Metabolic Syndrome and Obesity. Volume 3. 357–361. 9 indexed citations

17.

Vetter, Marion, et al.. (2009). Narrative Review: Effect of Bariatric Surgery on Type 2 Diabetes Mellitus. Annals of Internal Medicine. 150(2). 94–103. 142 indexed citations

18.

Sarwer, David B., et al.. (2009). Behavior therapy for obesity: where are we now?. Current Opinion in Endocrinology Diabetes and Obesity. 16(5). 347–352. 94 indexed citations

19.

Vetter, Marion, et al.. (2008). Tyrosine Kinase Inhibitors and the Thyroid as Both an Unintended and an Intended Target. Endocrine Practice. 14(5). 618–624. 16 indexed citations

20.

Vetter, Marion, et al.. (2008). What Do Resident Physicians Know about Nutrition? An Evaluation of Attitudes, Self-Perceived Proficiency and Knowledge. Journal of the American College of Nutrition. 27(2). 287–298. 236 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact